Partell Specialty Pharmacy Recalls Ascorbic Acid Vials Due to Sterility Concerns
Partell Specialty Pharmacy is recalling Ascorbic Acid (Tapioca) 500 mg/mL vials because they were sterilized using a non-approved method.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric for significant injury or property damage reports, or high-risk scenarios.
Plain-English summary
Partell Specialty Pharmacy is recalling specific lots of Ascorbic Acid (Tapioca) 500 mg/mL, 50 mL amber vials. The recall is being conducted because the firm used a non-approved method of sterilization for these drug products, resulting in a lack of assurance of sterility.
The affected product is prescription-only and was distributed only in Nevada. The recall includes four vials from the following lots: 20180201@34 (expiration 04/02/2018), 20180202@56 (expiration 04/03/2018), 20180129@41 (expiration 3/30/2018), and 20180207@16 (expiration 04/08/2018).
Consumers and healthcare providers should stop using these products and contact Partell Specialty Pharmacy at (702) 791-3800 for further instructions.
The recalled product
- Product
- Ascorbic Acid (Tapioca) 500 mg/mL, 50 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800
- Manufacturer
- Partell Specialty Pharmacy
- Category
- Drug — Sterile Injectable
- Hazard
- Affected units
- 4
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot#: 20180201@34
- BUD 04/02/2018
- 20180202@56
- BUD 04/03/2018
- 20180129@41
- BUD 3/30/2018
- 20180207@16
- BUD 04/08/2018.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 49 recalled by Partell Specialty Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 49 products in this recall →Related recalls
Same manufacturer · Partell Specialty Pharmacy
See all →- SeverePartell Specialty Pharmacy Recalls Glutathione Vials Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Nandrolone Decanoate Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- HighPartell Specialty Pharmacy Recalls Estradiol Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Testosterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls CoEnzymeQ10 Vials Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SeverePromise Pharmacy Recalls Ascorbic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2019-02-20
- SevereTri-Coast Pharmacy Recalls Ascorbic Acid Vials Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereKRS Global Biotechnology Recalls Ascorbic Acid Vials Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
- SevereGuardian Pharmacy Recalls Ascorbic Acid Vials Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SevereGreen Valley Drugs Recalls Ascorbic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- HighAscorbic Acid Injectable Vials Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-07-20